Science Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2022-05-25 aming1982

审稿速度:2.0 | 投稿命中率:5.0
经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄

264 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2019-06-30 水地比

想问下to advisor 这个状态大概持续多久呢？谢谢

490 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2021-12-27 衣谷

题目中是否需要对专有名词进行缩写？

309 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2021-12-27 rayms

什么是RUNINGTITLE?

311 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2021-10-01 12439d90m12暂无昵称

需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定

323 0

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2021-09-02 可爱的小医生，努力中

这个杂志临床 letter要不

250 0

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2021-04-10 青哥

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：脑缺血;胶质细胞;信号转导
经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。
很喜欢STM，也算圆了自己的梦想。

333 0

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2020-05-16 hailiang559

under evaluation状态会持续多久呢？谢谢

262 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2019-04-29 sunliang

恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表:
我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM

drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM

481 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104079, encodeId=23d511040e9d6, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104080, encodeId=2fb41104080a9, content=什么是RUNINGTITLE?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056817, encodeId=ece8105681eaa, content=需要新颖性的临床意义较大的工作量细致的逻辑一年的审稿修回终于得到国际顶级转化子刊的肯定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210118/2b8e238bb1ff4975a819b06092ff04a8/2bd106ee0f0242ed8c0bec6bcb12f965.jpg, createdBy=e5942471171, createdName=12439d90m12暂无昵称, createdTime=Fri Oct 01 17:42:29 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013713, encodeId=98171013e134f, content=这个杂志临床 letter要不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e01952902, createdName=可爱的小医生，努力中, createdTime=Thu Sep 02 10:44:54 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955641, encodeId=7f4295564199, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：脑缺血;胶质细胞;信号转导 经验分享：20191126投稿，投STM前已经试过很多杂志，根据反馈意见补了半年多实验，感觉对文章有了质的提升才开始投稿。两周后送审，意见在一个半月左右回来，两个审稿人。一个没有大问题，另一个建议转投其他杂志，editor因此很官方的拒了。我们针对两个editor的大小二十几个问题一一做了详细回复，editor重新评估后给了resubmit的机会。20200723重新投回去，还是一个半月左右，还是前面的两个审稿人，这次都没有任何问题了。至此进入小修阶段，两次小修，每次在两个半月左右。 很喜欢STM，也算圆了自己的梦想。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/452B2C2B4A1F021FDE3F7C17688895D1/100, createdBy=c0fa2161077, createdName=青哥, createdTime=Sat Apr 10 09:36:53 CST 2021, time=2021-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590972, encodeId=13e75909e281, content=under evaluation状态会持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c21631482, createdName=hailiang559, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570211, encodeId=c29f5e021134, content=恭喜啊，STM很好的杂志，未来破20，指日可待啊drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, beContent=drCHD 2019-04-25 00:00:00 发表: 我们的STM终于见刊了。对于此杂志的审稿过程要有充分思想准备，时间漫长，审稿苛刻需非常尽力补实验来回答评委近乎苛刻的意见。审稿流程和science一样，先编辑看，拒10%.然后科学委员会的评委打分，拒60%. 剩余40%有外审机会，外审后拒一半，还有一半给修回机会，修回后再拒一半，最后只有百分之七到十左右最后接受率。这一年每天看状态更新都成为生活一部分了。终于坚持下来了。特的写出来给大家参考，希望更多中国研究发到STM, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806675, encodeId=98de8066e5a3, content=想请问大家整个流程是一年么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449d5227259, createdName=14792243m68暂无昵称, createdTime=Thu Aug 06 22:47:54 CST 2020, time=2020-08-06, status=1, ipAttribution=)]

2020-08-06 14792243m68暂无昵称

想请问大家整个流程是一年么

184 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务